{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:36:48Z","timestamp":1791380208113,"version":"4.3.3"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ebiom.2024.105481","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T08:15:56Z","timestamp":1733472956000},"page":"105481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Discovery and characterization of potent broadly neutralizing antibodies from human survivors of severe fever with thrombocytopenia syndrome"],"prefix":"10.1016","volume":"111","author":[{"given":"Shuo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengze","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongkai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6280-267X","authenticated-orcid":false,"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2024.105481_bib1","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1056\/NEJMoa1010095","article-title":"Fever with thrombocytopenia associated with a novel bunyavirus in China","volume":"364","author":"Yu","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2024.105481_bib2","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.3201\/eid2411.170756","article-title":"Severe fever with thrombocytopenia syndrome virus infection, South Korea, 2010","volume":"24","author":"Kim","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105481_bib3","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/infdis\/jit603","article-title":"The first identification and retrospective study of Severe Fever with Thrombocytopenia Syndrome in Japan","volume":"209","author":"Takahashi","year":"2014","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105481_bib4","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3201\/eid2505.181463","article-title":"Endemic severe fever with thrombocytopenia syndrome, Vietnam","volume":"25","author":"Tran","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105481_bib5","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3201\/eid2607.190611","article-title":"Serologic evidence of severe fever with thrombocytopenia syndrome virus and related viruses in Pakistan","volume":"26","author":"Zohaib","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105481_bib6","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.3201\/eid2608.200135","article-title":"Genotypic heterogeneity of orientia tsutsugamushi in scrub typhus patients and thrombocytopenia syndrome Co-infection, Myanmar","volume":"26","author":"Win","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105481_bib7","first-page":"204","article-title":"Severe fever with thrombocytopenia syndrome virus: the first case report in Thailand","volume":"16","author":"Ongkittikul","year":"2020","journal-title":"BKK Med"},{"key":"10.1016\/j.ebiom.2024.105481_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129531","article-title":"Genetic and pathogenic diversity of severe fever with thrombocytopenia syndrome virus (SFTSV) in South Korea","volume":"5","author":"Yun","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ebiom.2024.105481_bib9","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S1473-3099(18)30293-7","article-title":"Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study","volume":"18","author":"Li","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105481_bib10","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3201\/eid2405.151435","article-title":"Transmission of severe fever with thrombocytopenia syndrome virus by haemaphysalis longicornis ticks, China","volume":"24","author":"Zhuang","year":"2018","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105481_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009037","article-title":"Epidemiological and clinical characteristics of severe fever with thrombocytopenia syndrome bunyavirus human-to-human transmission","volume":"15","author":"Fang","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2024.105481_bib12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijid.2022.08.008","article-title":"Human-to-human transmission of severe fever with thrombocytopenia syndrome virus through potential ocular exposure to infectious blood","volume":"123","author":"Wu","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105481_bib13","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7883\/yoken.JJID.2018.526","article-title":"A\u00a0case of cat-to-human transmission of severe fever with thrombocytopenia syndrome virus","volume":"72","author":"Kida","year":"2019","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105481_bib14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.virs.2024.03.006","article-title":"Severe fever with thrombocytopenia syndrome virus infection attributed to cat contact: a case report in Beijing, China","volume":"39","author":"Zhang","year":"2024","journal-title":"Virol Sin"},{"key":"10.1016\/j.ebiom.2024.105481_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41392-021-00541-3","article-title":"Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ebiom.2024.105481_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009103","article-title":"A\u00a0multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome","volume":"15","author":"Suemori","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2024.105481_bib17","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.1073\/pnas.1603827113","article-title":"Structure of a phleboviral envelope glycoprotein reveals a consolidated model of membrane fusion","volume":"113","author":"Halldorsson","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2024.105481_bib18","article-title":"CCR2 is a host entry receptor for severe fever with thrombocytopenia syndrome virus","volume":"9","author":"Zhang","year":"2023","journal-title":"Sci Adv"},{"key":"10.1016\/j.ebiom.2024.105481_bib19","doi-asserted-by":"crossref","first-page":"E7564","DOI":"10.1073\/pnas.1705176114","article-title":"Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope","volume":"114","author":"Wu","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2024.105481_bib20","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/procel\/pwad019","article-title":"Architecture of severe fever with thrombocytopenia syndrome virus","volume":"14","author":"Sun","year":"2023","journal-title":"Protein Cell"},{"key":"10.1016\/j.ebiom.2024.105481_bib21","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1038\/s41467-023-41804-7","article-title":"Cryo-EM structure of severe fever with thrombocytopenia syndrome virus","volume":"14","author":"Du","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2024.105481_bib22","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.3201\/eid2211.160414","article-title":"Neutralizing antibodies to severe fever with thrombocytopenia syndrome virus 4 years after hospitalization, China","volume":"22","author":"Huang","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105481_bib23","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1038\/s41467-018-05746-9","article-title":"Deficient humoral responses and disrupted B-cell immunity are associated with fatal SFTSV infection","volume":"9","author":"Song","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2024.105481_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijid.2023.05.018","article-title":"Dynamics of neutralizing antibodies against severe fever with thrombocytopenia syndrome virus","volume":"134","author":"Li","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105481_bib25","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.3201\/eid2207.151791","article-title":"Use of plasma therapy for severe fever with thrombocytopenia syndrome encephalopathy","volume":"22","author":"Park","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105481_bib26","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.4269\/ajtmh.17-0766","article-title":"Case report: use of plasma exchange followed by convalescent plasma therapy in a critically ill patient with severe fever and thrombocytopenia syndrome-associated encephalopathy: cytokine\/chemokine concentrations, viral loads, and antibody responses","volume":"99","author":"Choi","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ebiom.2024.105481_bib27","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/infdis\/jiv144","article-title":"Phylogenetic and geographic relationships of severe fever with thrombocytopenia syndrome virus in China, South Korea, and Japan","volume":"212","author":"Yoshikawa","year":"2015","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.ebiom.2024.105481_bib28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12250-020-00289-0","article-title":"Novel SFTSV phylogeny reveals new\u00a0reassortment events and migration routes","volume":"36","author":"Wu","year":"2021","journal-title":"Virol Sin"},{"key":"10.1016\/j.ebiom.2024.105481_bib29","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1080\/22221751.2022.2081617","article-title":"Effect of genomic variations in severe fever with thrombocytopenia syndrome virus on the disease lethality","volume":"11","author":"Dai","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.ebiom.2024.105481_bib30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.meegid.2016.11.015","article-title":"Migration, recombination, and reassortment are involved in the evolution of severe fever with thrombocytopenia syndrome bunyavirus","volume":"47","author":"Shi","year":"2017","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.ebiom.2024.105481_bib31","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1128\/CVI.00222-13","article-title":"Human antibody neutralizes severe fever with thrombocytopenia syndrome virus, an emerging hemorrhagic fever virus","volume":"20","author":"Guo","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.ebiom.2024.105481_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007375","article-title":"An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus","volume":"15","author":"Kim","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2024.105481_bib33","first-page":"76","article-title":"Development of neutralizing antibodies against SARS-CoV-2, using a high-throughput single-B-cell cloning method","volume":"6","author":"Dou","year":"2023","journal-title":"Antib Ther"},{"key":"10.1016\/j.ebiom.2024.105481_bib34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/j.ebiom.2024.105481_bib35","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.ebiom.2024.105481_bib36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.ebiom.2024.105481_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci"},{"key":"10.1016\/j.ebiom.2024.105481_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005893","article-title":"Molecular genomic characterization of tick- and human-derived severe fever with thrombocytopenia syndrome virus isolates from South Korea","volume":"11","author":"Yun","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2024.105481_bib39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s42826-020-00070-0","article-title":"Pathogenicity of severe fever with thrombocytopenia syndrome virus in mice regulated in type I interferon signaling: severe fever with thrombocytopenia and type I interferon","volume":"36","author":"Park","year":"2020","journal-title":"Lab Anim Res"},{"key":"10.1016\/j.ebiom.2024.105481_bib40","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A\u00a0randomized, controlled trial of Ebola virus disease therapeutics","volume":"381","author":"Mulangu","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2024.105481_bib41","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1016\/j.cell.2021.05.001","article-title":"Protective neutralizing antibodies from human survivors of Crimean-Congo hemorrhagic fever","volume":"184","author":"Fels","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2024.105481_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00028-20","article-title":"Neutralizing monoclonal antibodies against the Gn and the Gc of the Andes virus glycoprotein spike complex protect from virus challenge in a preclinical hamster model","volume":"11","author":"Duehr","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.ebiom.2024.105481_bib43","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/s41564-019-0411-z","article-title":"Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus","volume":"4","author":"Wang","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.ebiom.2024.105481_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/v12030259","article-title":"Characterization of two neutralizing antibodies against rift valley fever virus Gn protein","volume":"12","author":"Hao","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ebiom.2024.105481_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/v14081665","article-title":"Neutralizing mAbs against SFTS virus Gn protein show strong therapeutic effects in an SFTS animal model","volume":"14","author":"Shimojima","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ebiom.2024.105481_bib46","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1073\/pnas.1921388117","article-title":"Longitudinal dynamics of the human B cell response to the yellow fever 17D vaccine","volume":"117","author":"Wec","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ebiom.2024.105481_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112503","article-title":"Fortuitous somatic mutations during antibody evolution endow broad neutralization against SARS-CoV-2 Omicron variants","volume":"42","author":"Wu","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2024.105481_bib48","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1128\/JVI.02628-12","article-title":"Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines","volume":"87","author":"Hofmann","year":"2013","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.ebiom.2024.105481_bib49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/JVI.02141-13","article-title":"Nonmuscle myosin heavy chain IIA is a critical factor contributing to the efficiency of early infection of severe fever with thrombocytopenia syndrome virus","volume":"88","author":"Sun","year":"2014","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.ebiom.2024.105481_bib50","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1038\/s41467-024-51108-z","article-title":"A\u00a0broadly protective antibody targeting glycoprotein Gn inhibits severe fever with thrombocytopenia syndrome virus infection","volume":"15","author":"Ren","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2024.105481_bib51","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2400163121","article-title":"Bispecific antibodies targeting two glycoproteins on SFTSV exhibit synergistic neutralization and protection in a mouse model","volume":"121","author":"Chang","year":"2024","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424005176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424005176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T03:08:53Z","timestamp":1736824133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424005176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":51,"alternative-id":["S2352396424005176"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105481","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery and characterization of potent broadly neutralizing antibodies from human survivors of severe fever with thrombocytopenia syndrome","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105481"}}